Sort by
Refine Your Search
-
the Alliance for Therapies in Neuroscience (ATN), a research partnership between academia and industry to transform the fight against brain diseases and disorders of the central nervous system. The successful
-
the transition to a sustainable energy future. SOECs, which operate at high temperature (typically in the range of 600 to 850 °C), offer the highest efficiency among different electrolysis technologies
-
iNANO at Aarhus University is seeking a postdoctoral fellow for the Novo Nordisk Foundation CO2 R...
to, basic electron transport between cells and a cathode, microbe-cathode interfaces, and the new design and prototyping of microbial electrosynthesis reactors. What we offer Exciting, interdisciplinary
-
to, basic electron transport between cells and a cathode, microbe-cathode interfaces, and the new design and prototyping of microbial electrosynthesis reactors. What we offer Exciting, interdisciplinary
-
, beginning July 1, 2024 by the Alliance for Therapies in Neuroscience (ATN), a research partnership between academia and industry to transform the fight against brain diseases and disorders of the central
-
regional entanglements with and responses to different imperial hegemonies. LoCiS aims to reveal new knowledge about intersecting identities on an individual, local and regional level through a long durée
-
Overview The VIB-KU Leuven Center for Brain & Disease Research is part of the VIB Life Sciences Institute and is embedded within the KU Leuven, which ranks among the world’s top 50 universities
-
Monitoring (LTVEM) in the hospital for management and diagnosis of epilepsy. The technology is built on brain computer interfaces equipped with a Spiking Neural Network (SNN) and aims at early detection
-
expertise in sensory processing (visual, auditory, and olfactory), motor control, naturalistic behavior, neural engineering, and brain-computer interfaces. The Oregon NeuroAI Center is part of the Institute
-
the Alliance for Therapies in Neuroscience (ATN), a research partnership between academia and industry to transform the fight against brain diseases and disorders of the central nervous system. The successful